Colin Davis

CRS:

Whitman-Walker

Role:

Research Staff

Position:

Study Coordinator

Colin Davis joined the Whitman-Walker research team as the REPRIEVE study coordinator in July 2016, though he has volunteered with the Gay Men’s Health & Wellness Clinic since 2014. After studying biology and English at William & Mary, Colin fostered an interest in HIV, community health, and LGBT-care through GWU’s graduate certificate program in LGBT Health, an interest he is thrilled to realize through his work with Whitman-Walker. 

Categories

Leadership Committees
CRS
Roles

Clinical Trials

A5290: Randomized, Phase 2b Study of a Double-Dose...

Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...

Read More

P1060:  Phase II, parallel, randomized, clinical trials...

A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been...

Read More

P1077FF: Formula Feeding Version of the PROMISE Study...

1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...

Read More

A5322: Long-Term Follow-up of Older HIV-infected Adults in...

The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...

Read More

A5273: Multicenter Study of Options for Second-Line...

The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...

Read More